Changhua Chemical Technology (301518.SZ) plans to repurchase shares in the amount of 10-20 million yuan, with a special loan of no more than 14 million yuan already obtained.
Changhua Chemical (301518.SZ) announced that the company plans to invest 10 million to 20 million yuan to repurchase shares.
Changhua Chemical Technology (301518.SZ) announced that the company plans to invest 10 to 20 million yuan to repurchase shares, with a maximum repurchase price of no more than 25 yuan per share, to be used for employee stock ownership plans or equity incentives.
Source of funds: The company's own funds and a special stock repurchase loan provided by the China Construction Bank Corporation's Zhangjiagang Branch, with a maximum loan amount of 14 million yuan. The company will apply for the repurchase loan funds as needed, with the loan amount not exceeding 70% of the actual repurchase amount. Repurchase loan fund situation: On November 5th, the company obtained a "China Construction Bank Corporation Loan Commitment Letter" from the China Construction Bank Corporation's Zhangjiagang Branch, agreeing to provide a special loan of up to 14 million yuan for the company's stock repurchase, with a loan term of 1 year. Loan terms are subject to the latest regulatory requirements.
Related Articles

HK Stock Market Move | Oil shipping prices in two major sub-sectors rise, COSCO SHIPPING Energy Transportation (01138) surges over 4%, The Pacific Shipping (02343) rises over 3%.

HK Stock Market Move | HBM HOLDINGS-B (02142) surged over 4% in early trading as the Phase II trial of the long-acting TSLP antibody for asthma was successful, and the Phase III clinical trial has now started.

Founder: Functional diamond goes from discretionary consumption to AI materials, achieving dual breakthroughs in heat dissipation and PCB processing.
HK Stock Market Move | Oil shipping prices in two major sub-sectors rise, COSCO SHIPPING Energy Transportation (01138) surges over 4%, The Pacific Shipping (02343) rises over 3%.

HK Stock Market Move | HBM HOLDINGS-B (02142) surged over 4% in early trading as the Phase II trial of the long-acting TSLP antibody for asthma was successful, and the Phase III clinical trial has now started.

Founder: Functional diamond goes from discretionary consumption to AI materials, achieving dual breakthroughs in heat dissipation and PCB processing.

RECOMMEND





